Yukihisa Inoue Osamu Matsubara Yumi Ohira Satoshi Endo Yasuto Jinn
10.1016/j.rmcr.2021.101418
Respir Med Case Rep
2021 Apr 13;33:101418.
alk rearrangement alk, anaplastic lymphoma kinase alectinib cea, carcinoembryonic antigen ct, computed tomography egfr mutation egfr, epidermal growth factor receptor ggn, ground glass nodule lll, left lower lobe lul, left upper lobe nsclc, non-small cell lung cancer osimertinib rll, right lower lobe rul, right upper lobe smplc, synchronous multiple primary lung cancers synchronous multiple primary lung cancers
CC BY-NC-ND
https://pubmed.ncbi.nlm.nih.gov/34401266/
Case Reports
PMC8348148
34401266
A case of synchronous multiple primary lung adenocarcinomas harboring epidermal growth factor receptor mutation and anaplastic lymphoma kinase rearrangement successfully treated with combination of osimertinib and alectinib
2021